PUBLICATION

Loss of Pten promotes angiogenesis and enhanced vegfaa expression in zebrafish

Authors
Choorapoikayil, S., Weijts, B., Kers, R., de Bruin, A., and den Hertog, J.
ID
ZDB-PUB-130708-29
Date
2013
Source
Disease models & mechanisms   6(5): 1159-66 (Journal)
Registered Authors
Choorapoikayil, Suma, den Hertog, Jeroen, Weijts, Bart
Keywords
none
MeSH Terms
  • Animals
  • Chromones/pharmacology
  • Chromones/therapeutic use
  • Drug Therapy, Combination
  • Endothelial Cells/metabolism
  • Endothelial Cells/pathology
  • Haploinsufficiency/drug effects
  • Haploinsufficiency/genetics
  • Hemangiosarcoma/blood supply
  • Hemangiosarcoma/drug therapy
  • Hemangiosarcoma/pathology
  • Humans
  • Indoles/pharmacology
  • Indoles/therapeutic use
  • Morpholines/pharmacology
  • Morpholines/therapeutic use
  • Mutation/genetics
  • Neovascularization, Pathologic/drug therapy
  • Neovascularization, Pathologic/metabolism*
  • Neovascularization, Pathologic/pathology*
  • Phosphoprotein Phosphatases/deficiency*
  • Phosphoprotein Phosphatases/genetics
  • Phosphoprotein Phosphatases/metabolism
  • Proto-Oncogene Proteins c-akt/metabolism
  • Pseudopodia/drug effects
  • Pseudopodia/metabolism
  • Pyrroles/pharmacology
  • Pyrroles/therapeutic use
  • RNA, Messenger/genetics
  • RNA, Messenger/metabolism
  • Up-Regulation/drug effects
  • Vascular Endothelial Growth Factor A/metabolism*
  • Zebrafish/embryology
  • Zebrafish/metabolism*
  • Zebrafish Proteins/deficiency*
  • Zebrafish Proteins/genetics
  • Zebrafish Proteins/metabolism*
PubMed
23720233 Full text @ Dis. Model. Mech.
Abstract

Angiogenesis, the emergence of vessels from an existing vascular network, is pathologically associated with tumor progression and is of great interest for therapeutic intervention. PTEN is a frequently mutated tumor suppressor and has been linked to the progression of many types of tumors, including hemangiosarcomas in zebrafish. Here, we report that mutant zebrafish embryos lacking functional Pten exhibit enhanced angiogenesis, accompanied by elevated levels of phosphorylated Akt (pAkt). Inhibition of phosphoinositide 3-kinase (PI3K) by LY294002 treatment and application of sunitinib, a widely used anti-angiogenic compound, suppressed enhanced angiogenesis in Pten mutants. Vegfaa has a crucial role in angiogenesis and vegfaa expression was upregulated in embryos lacking functional Pten. Interestingly, vegfaa expression was also upregulated in hemangiosarcomas from haploinsufficient adult zebrafish Pten mutants. Elevated vegfaa expression in mutant embryos lacking functional Pten was suppressed by LY294002. Surprisingly, sunitinib treatment dramatically enhanced vegfaa expression in Pten mutant embryos, which might account for tumor relapse in human patients who are treated with sunitinib. Combined treatment with suboptimal concentrations of sunitinib and LY294002 rescued enhanced angiogenesis in pten mutant embryos without the dramatic increase in vegfaa expression, suggesting a new approach for therapeutic intervention in VEGFR-signaling-dependent tumors.

Genes / Markers
Figures
Show all Figures
Expression
Phenotype
Mutations / Transgenics
Human Disease / Model
Sequence Targeting Reagents
Fish
Antibodies
Orthology
Engineered Foreign Genes
Mapping